KR
Kalpit Rajesh Gandhi
About Kalpit Rajesh Gandhi
Data last updated:
Kalpit Rajesh Gandhi is a Whole-Time Director at Vadilal Enterprises Limited (since 2025), Director at Senores Pharmaceuticals Limited (since 2024) and Director at Ratnatris Pharmaceuticals Private Limited (since 2024), and holds 7 more current directorships. The companies operate in Food and Beverages, Pharma and Financial Services. The 8 current companies with reported revenue have a combined latest revenue of ₹1,793 Cr; the largest is Vadilal Enterprises Limited at ₹1,223 Cr (FY 2026). Earlier, Kalpit Rajesh Gandhi was a Cfo at Vadilal Industries Limited (2014–2025) and Director at Vadilal Chemicals Limited (2015–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 14 Aug 2025 | 1985 | ₹1,223 Cr (FY 2026) | Active | |
| Director | 30 Jan 2024 | 2017 | ₹418 Cr (FY 2025) | Active | |
| Director | 12 Jun 2024 | 2005 | ₹142 Cr (FY 2025) | Active | |
| Director | 20 Dec 2009 | 1986 | ₹8.54 Cr (FY 2025) | Active | |
| Director | 13 May 2025 | 1995 | ₹1.91 Cr (FY 2025) | Active | |
| Director | 15 Jul 2025 | 1984 | ₹30.1 Lakh (FY 2025) | Active | |
| Director | 13 May 2025 | 1984 | ₹21.4 Lakh (FY 2025) | Active | |
| Director | 11 Jan 2015 | 1985 | ₹15.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 01 Jun 2014 | 1982 | ₹1,255 Cr (FY 2025) | Active | |
| Director | 31 Mar 2015 | 1991 | ₹77.84 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kalpit Rajesh Gandhi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kalpit Rajesh Gandhi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalpit Rajesh Gandhi
Kalpit Rajesh Gandhi currently holds 10 directorships: Vadilal Enterprises Limited (Whole-Time Director, since 14 Aug 2025, revenue ₹1,223 Cr (FY 2026)); Senores Pharmaceuticals Limited (Director, since 30 Jan 2024, revenue ₹418 Cr (FY 2025)); Ratnatris Pharmaceuticals Private Limited (Director, since 12 Jun 2024, revenue ₹142 Cr (FY 2025)); Vadilal International Private Limited (Director, since 20 Dec 2009, revenue ₹8.54 Cr (FY 2025)); Veronica Constructions Pvt Ltd (Director, since 13 May 2025, revenue ₹1.91 Cr (FY 2025)); and 5 more.
Kalpit Rajesh Gandhi was first appointed on 20 Dec 2009 as Director at Vadilal International Private Limited. The most recent appointment on record is 14 Aug 2025 at Vadilal Enterprises Limited.
The 8 current companies of Kalpit Rajesh Gandhi that report revenue have a combined latest revenue of ₹1,793 Cr: Vadilal Enterprises Limited ₹1,223 Cr (FY 2026); Senores Pharmaceuticals Limited ₹418 Cr (FY 2025); Ratnatris Pharmaceuticals Private Limited ₹142 Cr (FY 2025); Vadilal International Private Limited ₹8.54 Cr (FY 2025); Veronica Constructions Pvt Ltd ₹1.91 Cr (FY 2025); and 3 more.
Kalpit Rajesh Gandhi held 2 earlier board appointments: Vadilal Industries Limited (Cfo, 01 Jun 2014 to 13 May 2025); Vadilal Chemicals Limited (Director, 31 Mar 2015 to 19 Jul 2024).
The current boards of Kalpit Rajesh Gandhi's companies include Devanshubhai Laxmanbhai Gandhi (Vadilal Enterprises Limited), Janmejay Virendrabhai Gandhi (Vadilal Enterprises Limited), Mansi Janmejay Vyas (Vadilal Enterprises Limited), Nikita Panjumal Udhani (Vadilal Enterprises Limited), Rajesh Indermohan Bhagat (Vadilal Enterprises Limited), Rajesh Kantilal Pandya (Vadilal Enterprises Limited), among others.